Table 1.

Demographic and clinical characteristics of patients

Age, years (mean±SD)	60.6±8.2
BMI, kg/m2 (mean±SD)	27.6±4.2
Men, n (%)	98 (64.1%)
Women, n (%)	55 (35.9%)
Smoking, n (%)	32 (21%)
Diabetes mellitus, n (%)	67 (43.8%)
Hypertension, n (%)	109 (71.2%)
Previous MI, n (%)	18 (11.8%)
Previous PCI, n (%)	69 (45.1%)
Previous CABG, n (%)	29 (9.5%)
Creatinin, mg/dL (mean±SD)	0.9±0.2
TC, mg/dL (mean±SD)	180.7±28.2
TG, mg/dL (mean±SD)	131.7±58.4
LDL-C, mg/dL (mean±SD)	109.3±28.6
HDL-C, mg/dL (mean±SD)	41.5±13.8
LVEF, % (mean±SD)	67.3±3.5
Statin user, n (%)	79 (52%)
Beta-blocker user, n (%)	36 (23.5%)
ACEI-ARB user, n (%)	19 (12.5%)
Beta-blocker + ACEI-ARB user	79 (58.8%)

ACEI/ARB - angiotensin converting enzyme inhibitors/angiotensin receptor blockers; BMI - body mass index; CABG - coronary artery bypass grafting; HDL-C - high density lipoprotein cholesterol; LDL-C - low density lipoprotein cholesterol; LVEF (%) - left ventricular ejection fraction (%); MI - myocardial infarction; PCI - percutaneous coronary intervention; TC - total cholesterol; TG - triglyceride; SD- standard deviation